AWARD OUTCOME
What happened
Defence Equipment and Support has published a transparency notice stating its intention to directly award BBI SOLUTIONS OEM LIMITED an interim supply arrangement for currently fielded lateral flow devices supporting MOD biological detection capability.
Published outcomeThe named award remains pending. The notice does not evidence a signed or active contract.
Market significanceThe notice describes a proposed direct award of approximately £41m excluding VAT, intended to preserve supply continuity while the MOD runs a later open competition for the longer-term requirement.
AWARDED SUPPLIERS AND LOTS
1 supplier record analysed
BBI SOLUTIONS OEM LIMITED
99% confidenceAward 1 · Lots 1 · £41,000,000 excluding VAT; £49,200,000 gross stated for the single pending award GBP · Verified legal supplier named on pending award
View supporting evidence
Award 1 names supplier GB-COH-08368483. Supplier verification matches Companies House number 08368483 to BBI SOLUTIONS OEM LIMITED.
LIFECYCLE
Award or contract stage
Notice type
99% confidenceTransparency notice on Find a Tender (UK5)
View supporting evidence
Published document is described as a “Transparency notice on Find a Tender”; award document noticeType is UK5.
Procurement status
99% confidenceTender/lot marked complete; award marked pending
View supporting evidence
Tender and lot 1 status are “complete”; award 1 status is “pending”.
Contract conclusion
99% confidenceNot evidenced
View supporting evidence
The description says the authority “intends to award”; award 1 is pending and a future signature milestone is scheduled.
VALUES
Published values explained
Award value excluding VAT
99% confidence£41,000,000
View supporting evidence
Award 1 value.amount is 41000000 GBP; notice description says approximately £41m excluding VAT.
Award gross value
99% confidence£49,200,000
View supporting evidence
Award 1 value.amountGross is 49200000 GBP.
Value allocation
96% confidenceSingle award covering lot 1; no separate lot value published
View supporting evidence
Award 1 is related to lot 1; lot record has no value amount.
TIMELINE
Procurement timeline
Transparency notice published
99% confidence12 October 2026
View supporting evidence
Notice publication timestamp: 2026-10-12T17:15:37+01:00.
Scheduled future signature date
99% confidence30 September 2028
View supporting evidence
Award milestone type futureSignatureDate has dueDate 2028-09-30T23:59:59+01:00 and status scheduled.
Published contract period start
99% confidence1 April 2029
View supporting evidence
Award contractPeriod startDate is 2029-04-01.
Published contract period end
99% confidence31 March 2033
View supporting evidence
Award contractPeriod endDate is 2033-03-31.
SCOPE
What was awarded
Requirement
99% confidenceContinued manufacture and supply of currently fielded lateral flow devices (LFDs)
View supporting evidence
Tender description states the intended award is for continued manufacture and supply of the currently fielded LFDs.
Operational context
98% confidenceMOD biological detection and identification capability
View supporting evidence
The description calls LFDs a critical component of MOD biological detection and identification capability.
Category
99% confidenceGoods
View supporting evidence
Award 1 mainProcurementCategory is goods.
Classifications
99% confidenceCPV 33600000 Pharmaceutical products; CPV 33680000 Pharmaceutical articles
View supporting evidence
Award item 1 lists these CPV classifications.
PROCEDURE
Procedure and competition
Procedure
99% confidenceDirect award
View supporting evidence
Tender procurementMethod is direct and procurementMethodDetails is Direct award.
Stated legal basis
98% confidenceSection 41(1) and Schedule 5, Procurement Act 2023; technical reasons
View supporting evidence
Procurement rationale cites Section 41(1), Schedule 5 and absence of competition for technical reasons.
Authority's stated rationale
97% confidenceBBI is stated to be the only supplier able to manufacture the extant LFDs to the required specification and timescale; transition is stated to risk supply continuity.
View supporting evidence
Published procurement rationale cites validated processes, know-how, quality assurance, specialist reagents, supply chain and the time required for transfer and validation.
Competition
98% confidenceNo competitive bid process or bid count published; authority states a future open competition is intended
View supporting evidence
The procedure is direct. The description says the arrangement is interim while a full open commercial competition is undertaken.
CONTRACT TERMS
Published contract terms
Published base period
98% confidence4 years, from 1 April 2029 to 31 March 2033
View supporting evidence
The notice describes a four-year period; the award contractPeriod spans these dates.
Options
99% confidenceTwo optional one-year periods
View supporting evidence
Award options description: “Two Option Years of One Year Each”.
Option-date treatment
97% confidenceOption exercise dates are not published
View supporting evidence
The stated contract period ends on 31 March 2033, while the notice separately describes two option years.
COMMERCIAL VIEW
Commercial observations
Interim continuity arrangement
98% confidenceThe authority describes the proposed award as an interim measure pending a longer-term competitive procurement.
View supporting evidence
Tender description and procurement rationale explicitly state that a future competitive procurement is intended.
Technical transition barrier
97% confidenceThe authority states that transferring production would require technology transfer, validation, testing and assurance activity that cannot be completed in the required timeframe.
View supporting evidence
Published direct-award rationale.
DATA QUALITY
Gaps and source limitations
Award-state distinction
99% confidenceAlthough the process display status is awarded/complete, the individual award is pending and future signature is scheduled; this analysis does not treat it as signed or active.
View supporting evidence
Process display_status is awarded and source_status complete; award 1 status is pending; futureSignatureDate is scheduled.
Term ambiguity
98% confidenceThe published four-year contract period ends in March 2033, but two additional one-year options are also stated. Information on option timing and whether the published period includes options is not supplied.
View supporting evidence
contractPeriod is 2029-04-01 to 2033-03-31; options description states two one-year option years.
Information not supplied in the published notice
97% confidenceNo award decision date, signature confirmation, pricing breakdown, individual lot value, bid count, evaluation detail, or future competition timetable is published.
View supporting evidence
Relevant fields are absent or null in the supplied notice data.
SOURCE DATA LIMITATIONS
Information not supplied in the published notice
- The notice is an intended direct award transparency notice, not evidence of a signed or active contract; award 1 is pending.
- The four-year published contract period and the separate two one-year options do not establish the dates or exercise mechanism for the options.
- No award decision date, signature confirmation, bid count, evaluation information, lot-level value, detailed pricing, or timetable for the stated future competition is supplied.
MARKET THEMES
Relevant award themes
BBI SOLUTIONS OEM LIMITEDDefence Equipment and SupportMODlateral flow devicesdirect awardtransparency noticeCBRN
COMMON QUESTIONS
About this award
Has the contract been signed?
No. The published award is pending and lists a scheduled future signature date; the notice states that the authority intends to award.
What is the published value?
The single pending award is £41m excluding VAT and £49.2m gross.
Why is this a direct award?
The authority states that technical reasons and continuity requirements mean BBI is currently the only supplier able to produce the extant devices within the required timeframe.
ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.